Ask AI

A Practical Framework for Clinical Integration of ADCs Into Individualized Treatment Plans for Patients With NSCLC

Gain in-depth knowledge on current antibody–drug conjugates for non-small-cell lung cancer (NSCLC), including their targets, efficacy, and safety, to guide individualized treatment plans and manage adverse events through an on-demand webcast, expert-written ClinicalThought commentary, and accompanying downloadable slides.

Share

Program Content

Activities

ADCs in NSCLC
A Practical Framework for Clinical Integration of ADCs Into Individualized Treatment Plans for Patients With NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2025

Expires: November 27, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.